Aren't We All Already 'Ethicists'?

In his letter (The Scientist, Feb. 5, 1996, page 13) Arthur W. Galston appears to be of the opinion that "scientists ought to learn something about ethical theories" before they can "venture ethical pronouncements on that subject." Could Galston be a little confused about what constitutes a moral problem and, further, how we should go about solving such a problem? Perhaps Galston, like so many contemporary moral philosophers, has fallen for the idea that if there is no agreement on an issue, w

Written byBrian Everill
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In his letter (The Scientist, Feb. 5, 1996, page 13) Arthur W. Galston appears to be of the opinion that "scientists ought to learn something about ethical theories" before they can "venture ethical pronouncements on that subject." Could Galston be a little confused about what constitutes a moral problem and, further, how we should go about solving such a problem?

Perhaps Galston, like so many contemporary moral philosophers, has fallen for the idea that if there is no agreement on an issue, we cannot really know whether our views are right or wrong, good or evil.

Now, it is possible to ask ourselves which of two competing physiological theories about a particular plant is the correct one. But what do we wish to know if we ask which morality is the correct one? We can imagine in the case of the conflicting theories about plant physiology the type of empirical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies